SEC Form 4 · accession 0001140361-17-004437
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian T Dillon
Director
Period of report
Dec 12, 2016
Accepted (ET)
Feb 3, 2017 · 9:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2016 | M | 308 | $0.00 | A | 513 | D | |
| Common Stock | Feb 1, 2017 | A | 215 | $0.00 | A | 728 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Dec 12, 2016 | M | 308 | D | — | — | Common Stock | 308 | 0 | D |
| Restricted Stock UnitsF1,F3 | — | Feb 1, 2017 | A | 647 | A | — | — | Common Stock | 647 | 647 | D |
| Restricted Stock UnitsF1,F4 | — | Feb 1, 2017 | A | 1,778 | A | — | — | Common Stock | 1,778 | 1,778 | D |
| Stock Option (right to buy)F5 | $46.40 | Feb 1, 2017 | A | 4,837 | A | — | Feb 1, 2027 | Common Stock | 4,837 | 4,837 | D |
| Restricted Stock UnitF1,F6 | — | holding | — | — | — | — | — | Common Stock | 2,538 | 2,538 | D |
| Stock Option (right to buy)F7 | $32.50 | holding | — | — | — | — | Sep 1, 2026 | Common Stock | 7,632 | 7,632 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F2The restricted stock units vested on November 1, 2016 and were delivered to the reporting person on December 12, 2016.
- F3The restricted stock units vest as to 215 shares on May 1, 2017 and in two equal installments of 216 shares on August 1, 2017 and November 1, 2017. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."
- F4The restricted stock units vest as to 889 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."
- F5The option becomes exercisable as to 2,418 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will become exercisable on January 31, 2018.
- F6The restricted stock units vest in three equal annual installments of 846 shares on September 1, 2017, 2018, and 2019. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."
- F7The option becomes exercisable in three equal annual installments of 2,544 shares on September 1, 2017, 2018, and 2019.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney